Elixinol Wellness Ltd
ASX:EXL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its Industry Average (33.2), the stock would be worth AU$-0.44 (5 606% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.6 | AU$0.01 |
0%
|
| Industry Average | 33.2 | AU$-0.44 |
-5 606%
|
| Country Average | 22.3 | AU$-0.3 |
-3 798%
|
Forward P/E
Today’s price vs future net income
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| AU |
|
Elixinol Wellness Ltd
ASX:EXL
|
3.3m AUD | -0.6 | |
| FR |
|
L'Oreal SA
PAR:OR
|
195.2B EUR | 31.8 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
91.9B GBP | 11.2 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.4T INR | 37.8 | |
| UK |
|
HALEON PLC
LSE:HLN
|
30.3B GBP | 18.2 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27.4B USD | -153.8 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.4B EUR | 16.4 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 22.6 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 61.1 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
798.4B INR | 43.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.9 |
| Median | 22.3 |
| 70th Percentile | 36.3 |
| Max | 5 709.2 |
Other Multiples
Elixinol Wellness Ltd
Glance View
Elixinol Wellness Ltd. engages in the sale of nutraceutical and related hemp products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-01-08. The firm is engaged in marketing and selling hemp derived nutraceutical, cosmetic and food products. The company focuses on building its consumer brand portfolio via its manufacturing, research and development (R&D), and sales and marketing teams. Its businesses include Elixinol and Hemp Foods Australia. The Elixinol is the hemp derived cannabidiol (CBD) brands. The firm develops, manufactures and sells CBD products to consumers across the Americas, United Kingdom, Europe and other parts of the world. The Hemp Foods Australia is the hemp food wholesalers, retailers, manufacturers and exporters in Australia. The Hemp Foods Australia has a product range, including hemp seeds, hemp protein, hemp oil and hemp flour. The firm also manufactures hemp-based Sativa skincare range, as well as its plant-based Burger range.
